Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...

with an intracranial response rate of 63.6% with ensartinib versus 21.1% with crizotinib for the subset with measurable brain ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

Researchers have developed a method to program immune cells to target glioblastoma and reduce inflammation associated with ...

In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection ...

Researchers have created a "molecular GPS" to guide immune cells directly to the brain, enabling precise targeting of tumors ...

July 30, 2024 — A new study finds that giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast ...

UCSF scientists have developed a "molecular GPS" to guide immune cells into the brain and kill tumors without harming healthy ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

Scientists have developed a 'molecular GPS' to guide immune cells into the brain and kill tumors without harming healthy tissue.